Cytel Releases New Primer, Ebook on Synthetic Control Arms

Cytel has released a new ebook outlining the use cases and benefits of synthetic control arms in clinical trial settings, as well as a new scientific primer.

Synthetic control arms can draw on previously-collected data from clinical trials to replace the placebo and standard of care, Cytel says.

“This in turn saves the costs and times associated with patient recruitment and retention, while avoiding the need to give very ill patients an already well-tested candidate drug,” Cytel says in a blog post.

To read the full blog post, click here.